[Light and electron microscopic studies of the formation of the oocyst wall in Eimeria (Eimeria perforans, E. stiedae and E. tenella)].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 4908499)

Published in Z Parasitenkd on January 01, 1969

Authors

E Scholtyseck, A Rommel, G Heller

Articles by these authors

(truncated to the top 100)

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol (1992) 3.86

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature (2000) 2.84

Idiopathic hypertrophic pachymeningitis. Neurology (2004) 2.55

Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA (1991) 2.52

Further Studies upon the Effect of Various Carbohydrates on Production of Diphtheria Toxin with Special Reference to its Flocculating Titer and Final pH. J Bacteriol (1932) 2.36

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol (1991) 2.18

Clinical states in prostate cancer: toward a dynamic model of disease progression. Urology (2000) 2.16

Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a. Blood (1990) 2.08

Organization and nucleotide sequence of a transcriptional unit of Methanococcus vannielii comprising genes for protein synthesis elongation factors and ribosomal proteins. J Mol Evol (1989) 2.04

Clinical usefulness of pulse oximetry in the fetus with non-reassuring heart rate pattern? J Perinat Med (2000) 2.03

Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol (1993) 2.01

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol (1998) 1.81

International variations in infrainguinal bypass surgery - a VASCUNET report. Eur J Vasc Endovasc Surg (2012) 1.58

Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood (1993) 1.58

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood (1998) 1.57

The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am (1998) 1.56

Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med (1999) 1.55

Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood (1989) 1.52

Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer (1993) 1.51

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol (1992) 1.50

The phase II/III transition. Toward the proof of efficacy in cancer clinical trials. Control Clin Trials (2000) 1.46

Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short- and long-term cardiovascular events. Eur Heart J (1998) 1.43

CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia. Blood (1993) 1.41

Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review. Cancer (2001) 1.41

Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol (1999) 1.39

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol (1998) 1.36

The function of 80 S ribosomal subunits and effects of some antibiotics. Cold Spring Harb Symp Quant Biol (1969) 1.35

Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol (2001) 1.31

Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood (1991) 1.27

The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood (1996) 1.26

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol (1994) 1.26

Lower levels of occupation, income and education are strongly associated with a longer smoking duration: multivariate results from the 2001 Australian National Drug Strategy Survey. Public Health (2005) 1.26

The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res (2001) 1.24

The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer (1994) 1.23

Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. Cancer Res (1999) 1.20

Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant (1997) 1.19

Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol (2001) 1.16

Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery (1988) 1.14

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood (1994) 1.14

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. J Clin Oncol (2001) 1.13

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer (1996) 1.10

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol (1995) 1.10

Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant (1995) 1.10

[Utilization of outpatient and inpatient health services in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 1.08

Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol (1996) 1.08

Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood (1989) 1.08

Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol (1998) 1.07

Pediatric desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol (1995) 1.06

Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma. Clin Cancer Res (2000) 1.06

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer Res (1994) 1.05

Gene for the diphtheria toxin-susceptible elongation factor 2 from Methanococcus vannielii. Nucleic Acids Res (1988) 1.05

Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg (1998) 1.04

Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. J Clin Oncol (1998) 1.02

[Comparative morphological studies on the occurrence of pulmonary emphysema]. Frankf Z Pathol (1967) 1.02

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. J Clin Oncol (1998) 1.01

Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease. Bone Marrow Transplant (2007) 1.01

Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg (1994) 1.00

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? J Clin Oncol (1997) 0.99

Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Ther (2013) 0.99

[Complications in 4,000 arthroscopies]. Beitr Orthop Traumatol (1991) 0.98

Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol (1998) 0.98

Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.98

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol (2001) 0.98

Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. J Mol Diagn (2000) 0.97

Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood (1994) 0.95

Ultrastructural study of characteristic organelles (paired organelles, micronemes, micropores) of sporozoa and related organisms. Z Parasitenkd (1970) 0.94

Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol (2000) 0.94

Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood (1992) 0.94

Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. J Clin Oncol (1999) 0.94

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Ann Intern Med (1994) 0.93

Specific interactions of ribosomes in decoding. Cold Spring Harb Symp Quant Biol (1966) 0.93

Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage. Retina (2000) 0.92

Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant (1999) 0.91

Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma. Clin Orthop Relat Res (2001) 0.91

T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood (1992) 0.91

Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med (1996) 0.91

B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood (1990) 0.91

Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res (2000) 0.90

Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol (1998) 0.90

Growth in children after bone marrow transplantation for acute leukemia. Blood (1995) 0.89

A freeze-fracture electron microscope study of Trichomonas vaginalis Donné and Tritrichomonas foetus (Riedmüller). J Protozool (1984) 0.89

Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia (1994) 0.89

[Studies on the significance of carbohydrates in a fully synthetic fat-free diet]. Dtsch Med Wochenschr (1973) 0.88

Electron microscope studies of microgametogenesis in Coccidia and related groups. Z Parasitenkd (1972) 0.88

JunB is a gatekeeper for B-lymphoid leukemia. Oncogene (2007) 0.88

Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Semin Oncol (1989) 0.88

Electron microscope observations concerning the penetration of a host cell by Eimeria ferrisi in vivo. Z Parasitenkd (1975) 0.87

Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J Pediatr Surg (1992) 0.87

Common femoral artery--uncommon aneurysms. Scand J Surg (2003) 0.87

[Comparative study of the morphological and immunological relationship of coccidia of mice: Eimeria falciformes and Eimeria pragensis (Coccidia, Eimeriidae)]. Folia Parasitol (Praha) (1974) 0.87

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant (2012) 0.87

Bovine mesenteric vein graft (ProCol) in critical limb ischaemia with tissue loss and infection. Eur J Vasc Endovasc Surg (2004) 0.87

Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant (2007) 0.86

A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia. J Clin Oncol (1991) 0.86

Electron microscope observations on the interaction of Mycoplasma fermentans with Trichomonas vaginalis. Z Parasitenkd (1985) 0.85

[Electron microscopic studies on merozoites of Eimeria (Eimeria perforans and E. stidae) and Toxoplasma gondii. On the systematic position of T. gondii]. Z Parasitenkd (1965) 0.85

Fine structure of macrogametes and oocysts of Coccidia and related organisms. Z Parasitenkd (1971) 0.85

Validation of a technique of computer-aided tumor volume determination. J Surg Res (1995) 0.85

High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. J Clin Oncol (1998) 0.85